GRAIL, Inc. (GRAL) stock
GRALNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$99.25−5.59 (-5.33%)
Close on Nov 20, 2026Market cap $4.43BP/E –Yield –
Grail shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Grail's shares outstanding was 43M at Jun 30, 2026. For fiscal 2025 it was 37M, up 15.2% from the year before.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 37M | +15.2% |
| FY2024 | Dec 31, 2024 | 32M | +2.7% |
| FY2023 | Dec 31, 2023 | 31M | 0.0% |
| FY2022 | Jan 1, 2023 | 31M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 43M | +20.4% |
| Q1 FY2026 | Mar 31, 2026 | 41M | +18.5% |
| Q4 FY2025 | Dec 31, 2025 | 41M | +21.2% |
| Q3 FY2025 | Sep 30, 2025 | 36M | +13.3% |
| Q2 FY2025 | Jun 30, 2025 | 36M | +15.3% |
| Q1 FY2025 | Mar 31, 2025 | 34M | +10.5% |
| Q4 FY2024 | Dec 31, 2024 | 34M | +8.3% |
| Q3 FY2024 | Sep 30, 2024 | 32M | +2.7% |
| Q2 FY2024 | Jun 30, 2024 | 31M | 0.0% |
| Q1 FY2024 | Mar 31, 2024 | 31M | – |
| Q4 FY2023 | Dec 31, 2023 | 31M | – |
| Q3 FY2023 | Oct 1, 2023 | 31M | – |
| Q2 FY2023 | Jun 30, 2023 | 31M | – |
See a number that looks wrong?